Synthesis and DNA cleavage activity of a novel bleomycin A5 glycoconjugate

Organic Letters

Volumn 3, Issue 9, 2001, Pages 1291-1294

  Choudhury, Ambar K ^a   Tao, Zhi Fu ^a   Hecht, Sidney M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BLEOMYCIN A5; BLEOMYCIN A5 GLYCOCONJUGATE; DNA; DRUG DERIVATIVE;

ARTICLE; CATALYSIS; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; HUMAN; LIVER; METABOLISM; PLASMID; SQUAMOUS CELL CARCINOMA; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; CATALYSIS; DNA; HUMANS; LIVER; MOLECULAR STRUCTURE; PLASMIDS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0035799885     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol010015h     Document Type: Article

References (47)

1. (a) Hecht, S. M. In Cancer Chemotherapeutic Agents; Foye, W. O., Ed.; American Chemical Society: Washington, DC, 1995; pp 369-388.
2. (b) Hecht, S. M. J. Nat. Prod. 2000, 63, 158.
3. Bleomycin Chemotherapy; Sikic, B. I., Rozeneweig, M., Carter, S. K., Eds.; Academic Press: Orlando, FL, 1985.
4. (a) Hecht, S. M. Acc. Chem. Res. 1986, 19, 83.
5. (b) Kozarich, J. W.; Stubbe, J. Chem. Rer. 1987, 87, 1107.
6. (c) Natrajan, A.; Hecht, S. M. In Molecular Aspects of Anticancer Drug-DNA Interactions; Neidle, S., Waring, M. J., Eds.; Macmillan: London, 1980; pp 197-242.
7. (d) Kane, S. A.; Hecht, S. M. Prog. Nucl. Acid Res. Mol. Biol. 1994, 49, 313.
8. (e) Burger, R. M. Chem. Rev. 1998, 98, 1153.
9. (a) Hecht, S. M. Bioconjugate Chem. 1994, 5, 513.
10. (b) Holmes, C. D.; Duff, R. J.; van der Marel, G. A.; van Boom, J.; Hecht, S. M. Bioorg. Med. Chem. 1997, 5, 1235.
11. (c) Hecht, S. M. In The Many Faces of RNA; Eggleston, D. S., Prescott, C. D., Pearson, N. D., Eds.; Academic Press: San Diego, 1998; pp 3-17.
12. Tanaka, W. J. Antibiot. 1977, 30, S-41.
13. (a) Umezawa, H.; Hori, S.; Sawa, T.; Yoshioka, T.; Takeuchi, T. J. Antibiot. 1974, 27, 419.
14. (b) Lazo, J. S.; Boland, C. J.; Schwartz, P. E. Cancer Res. 1982, 42, 4026.
15. (c) Sebti, S. M.; DeLeon, J. C.; Ma, L.-T.; Hecht, S. M.; Lazo, J. S. Biochem. Pharmacol. 1989, 38, 141.
16. (d) Schwartz, D. R.; Homanics, G. E.; Hoyt, D. G.; Klein, E.; Abernethy, J.; Lazo, J. S. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 4680.
17. Tounekti, O.; Pron, G.; Belehradek, J. Jr.; Mir, L. M. Cancer Res. 1993, 53, 5462.
18. (a) Ashwell, G.; Harford, J. Annu. Rev. Biochem. 1982, 51, 531.
19. (b) Spiess, M. Biochemistry 1990, 29, 10009.
20. 8
21. (a) Biessen, E. A. L.; Beuting, D. M.; Roelen, H. C. P. F.; van der Marel, G. A.; van Boom, J. H.; van Berkel, T. J. C. J. Med. Chem. 1995, 38, 1538.
22. (b) Biessen, E. A. L.; Broxterman, H.; van Boom, J. H.; van Berkel, T. C. J. Med. Chem. 1995, 38, 1846.
23. (a) Lee, R. T.; Lin, P.; Lee, Y. C. Biochemistry 1984, 23, 4255.
24. (b) Peter, M. G.; Boldt, P. C.; Niederstein, Y.; Peter-Katalinic, J. Liebigs Ann. Chem. 1990, 863.
25. (c) Krebs, A.; Depew, W. T.; Szarek, W. A.; Hay, G. W.; Hronowski, L. J. J. Carbohydr. Res. 1994, 254, 257.
26. DeRiemer, L. H.; Meares, C. F.; Goodwin, D. A.; Diamanti, C. I. J. Med. Chem. 1979, 22, 1019.
27. See, for example: (a) Owa, T.; Haupt, A.; Otsuka, M.; Kobayashi, S.; Tomioka, N.; Itai, A.; Ohno, M.; Shiraki, T.; Uesugi, M.; Sugiura, Y.; Maeda, K. Tetrahedron 1992, 48, 1193.
28. (b) Hamamichi, N.; Natrajan, A.; Hecht, S. M. J. Am. Chem. Soc. 1992, 114, 6279.
29. (c) Quada, J. C. Jr.; Levy, M. J.; Hecht, S. M. J. Am. Chem. Soc. 1993, 115, 12171.
30. (d) Guajardo, R. J.; Hudson, S. E.; Brown, S. J.; Mascharak, P. K. J. Am. Chem. Soc. 1993, 115, 7971.
31. (e) Kane, S. A.; Natrajan, A.; Hecht, S. M. J. Biol. Chem. 1994, 269, 10899.
32. (f) Boger, D. L.; Honda, T.; Menezes, R. F.; Colletti, S. L.; Dang, Q.; Yang, W. J. Am. Chem. Soc. 1994, 116, 82.
33. (g) Boger, D. L.; Honda, T.; Menezes, R. F.; Colletti, S. L. J. Am. Chem. Soc. 1994, 116, 5631.
34. (h) Boger, D. L.; Teramoto, S.; Zhou, J. J. Am. Chem. Soc. 1995, 117, 7344.
35. (i) Katano, K.; An, H.; Aoyagi, Y.; Overhand, M.; Sucheck, S. J.; Stevens, W. C. Jr.; Hess, C. D.; Zhou, X.; Hecht, S. M. J. Am. Chem. Soc. 1998, 120, 11285.
36. Abraham, A. T.; Zhou, X.; Hecht, S. M. J. Am. Chem. Soc. 1999, 121, 1982.
37. Digenis, G. A.; Agha, B. J.; Tsuji, K.; Kato, M.; Shinogi, M. J. Med. Chem. 1986, 29, 1468.
38. 3: C, 43.36; H, 7.04; N, 3.37. Found: C, 43.62; H, 7.04; N, 3.33.
39. Medina, J. C.; Salomon, M.; Kyler, K. S. Tetrahedron Lett. 1988, 29, 3773.
40. Lonn, H. Carbohydr. Res. 1985, 139, 115.
41. For a formally analogous transformation, see: Nicolaou, K. C.; Seitz, S. P.; Papahatjis, D. P. J. Am. Chem. Soc. 1983, 105, 2430.
42. 2Na requires 2770.2).
43. Compound 8 was obtained as a mixture, contaminated predominantly with compounds resulting from the condensation of only one or two molecules of galactoside 7 with intermediate 6. A sample greatly enriched in 8 was obtained in 50% yield following chromatography on silica gel and then on Sephadex LH-20.
44. 14
45. (a) Castro, B.; Dormoy, J. R.; Evin, G.; Selve, C. Tetrahedron Lett. 1975, 16, 1219.
46. (b) Castro, B.; Dormoy, J. R.; Dourtoglou, B.; Evin, G.; Selve, C.; Ziegler, J. C. Synthesis 1976, 751.
47. (c) Castro, B.; Evin, G.; Selve, C.; Seyer, R. Synthesis 1977, 413.